Collegium Pharmaceuticalの空売り状況は、投資家がCollegium Pharmaceuticalの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Collegium Pharmaceutical (NASDAQ:COLL) 株価情報, 空売り情報

COLLEGIUM PHARMACEUTICAL INC

Collegium Pharmaceutical

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Collegium Pharmaceutical, Inc. - Common Stock

Collegium Pharmaceutical Inc

COLLEXIS HOLDINGS INC by Collexis Holdings, Inc.

CollPlant Biotechnologies Ltd. - Ordinary Shares

CollPlant Biotechnologies Ltd

Collaborative Investment Series Trust Anydrus Advantage ETF

Collaborative Investment Series Trust Goose Hollow Hedged Equity ETF

Collaborative Investment Series Trust Goose Hollow Multi-Strategy Income ETF

Collaborative Investment Series Trust MOHR IND NAV ETF

Collaborative Investment Series Trust Mohr Company Nav ETF

Collaborative Investment Series Trust Mohr Growth ETF

Collaborative Investment Series Trust Mohr Sector Nav ETF

Collaborative Investment Series Trust Rareview 2x Bull Cryptocurrency & Precious Metals ETF

Collaborative Investment Series Trust Rareview Inflation / Deflation ETF

Collaborative Investment Series Trust Rareview Systematic Equity ETF

Collaborative Investment Series Trust Rareview Total Return Bond ETF

COLLECTIVE AUDIENCE INC by Collective Audience, Inc.

Collective Audience Inc

COLLECTIVE METALS INC by COLLECTIVE METALS INC.

Collective Metals Inc

Collective Mining Ltd

Collective Mining Ltd Ordinary Shares

Colliers International Group Inc. - Subordinate Voting Shares

Colliers International Group Inc

COLLINS FOODS LTD NWMKT by Collins Foods Ltd Newmarket Qld

Collins Foods Ltd

Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) with a Buy and raises the price target from $119 to $125.

News

Price Target

Analyst Ratings

Citigroup Maintains Buy on Boston Scientific, Raises Price Target to $125

Chinese carmaker BYD Company ADR (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDY#OTC">BYDDY</a>) might have stolen the April electric vehicle title in Europe, but markets didn&#8217;t bat an eyelid. Neither did Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares.
<a href="https://www.benzinga.com/25/05/45564693/byd-outsells-elon-musks-tesla-amid-european-plans-shift-into-gear">BYD sold 7,231 battery electric cars (BEVs) in Europe in April</a>, edging out Tesla, which sold 7,165, new figures from JATO Dynamics show. Although the milestone represents a symbolic turning point in the European EV battle, it didn&#8217;t dent investor faith, as Tesla shares gained more than 2% on the day of the news.
It's the first time a Chinese brand has outsold Tesla in Europe's BEV segment, a region where the U.S. automaker has long held the pole position. BYD's ascent has been swift: the company began serious expansion into Europe only in late 2022. 
But markets appear to be betting that it&#8217;s only short-term turbulence for Tesla.
<h1 class="wp-block-heading">ETF Exposure: Why Tesla Still Matters</h1>
Tesla&#8217;s short fall in European rankings will be a speed bump, but for <a href="https://www.benzinga.com/etfs">ETFs tracking the EV and clean energy theme</a>, the larger picture still seems intact. 
Tesla is still a top holding in many of the large ETFs, like the ARK Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#BATS">ARKK</a>), Global X Autonomous &amp; Electric Vehicles ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRIV#NASDAQ">DRIV</a>), and iShares Self-Driving EV and Tech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDRV#NYSE">IDRV</a>), and today&#8217;s market response indicates that few are heading for the exits.
ARKK continues to hold a significant stake in Tesla (12.95%), relying on its push into autonomous mobility, artificial intelligence, and robotics. The upcoming robotaxi pilot and production of the Cybercab next year are part of ARKK's high-conviction, future-focused strategy. For investors betting on transformative tech, Tesla is still a solid play. The fund was up 1.42% at publication on Thursday.
ETFs like DRIV and IDRV has a wider exposure across the EV supply chain, including traditional automakers, chipmakers and software providers. Tesla is still one of the top holdings in both, but these funds also include companies like NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Toyota Motor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TM#NYSE">TM</a>), and Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), which help cushion any Tesla-specific volatility. 
This diversified approach makes it attractive to investors looking to benefit from the EV trend without putting all their chips on one automaker. Interestingly, though, IDRIV has rejigged its portfolio to dedicate the largest percentage distribution to BYD. Both the funds were fairly non-reactive to the news today.
Also Read: <a href="https://www.benzinga.com/markets/equities/25/05/45557873/tesla-bull-dan-ives-thinks-elon-musks-ev-giant-could-be-entering-a-golden-era-says-2-trillion-market-cap-on-the-table">Tesla Bull Dan Ives Thinks Elon Musk&#8217;s EV Giant Could Be Entering A &#8216;Golden Era,&#8217; Says 2 Trillion Market Cap &#8216;On The Table&#8217;</a>
<h1 class="wp-block-heading">Short-Term Wobble, Long-Term Vision</h1>
Tesla&#8217;s recent delivery downturn, continuing production interruptions and waiting for updated models such as the new Model Y have caused short-term headwinds. 
The stock is down more than 9% so far this year on an aggregate. Nevertheless, the company&#8217;s long-term strategy, backed by robotaxis, AI-based innovations, energy storage and next-generation vehicle platforms, is still compelling. Tesla&#8217;s pilot robotaxi launch will start as early as June in Austin, while a larger commercial fleet (Cybercab) is scheduled for 2026. 
For ETFs such as ARKK, which are constructed on narratives of innovation, Tesla still fits the thesis.
<h1 class="wp-block-heading">BYD&#8217;s Rise = A Diversification Opportunity</h1>
BYD&#8217;s increasing foothold in Europe, despite the tariffs on Chinese manufacturers imposed by the European Union, underscores the need for geographic diversification across EV ETFs. Funds like KraneShares Electric Vehicles and Future Mobility ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KARS#NYSE">KARS</a>), which encompass both Western and Chinese carmakers, are uniquely positioned to capitalize on the worldwide nature of EV growth. BYD is also growing rapidly, doubling international sales in April on a year-over-year basis, and establishing manufacturing platforms in Hungary and Turkey to circumvent EU import tariffs.
<h1 class="wp-block-heading">ESG Considerations And Musk&#8217;s Shadow</h1>
Tesla CEO Elon Musk, remains a magnet for attention, some of it unwanted. Protests and controversy surrounding his politics have generated backlash in the U.S. and Europe, creating an overhang for ESG-oriented funds. Nevertheless, for most ETFs, the firm&#8217;s role in electrification and renewable energy exceeds the reputation risk, at least in the short term.
<h1 class="wp-block-heading">Room To Grow</h1>
Tesla&#8217;s affordability, volume expansion, and capital-free manufacturing focus is unbroken. The firm is targeting lower-cost models and expanding production with minimal incremental capital, aiming for a 60% uplift ratio over 2024 levels. Its energy segment is also picking up, with record Powerwall installations and expanding margins.
<h1 class="wp-block-heading">Conclusion</h1>
BYD&#8217;s passing of Tesla in Europe&#8217;s EV rankings is news-worthy, but not necessarily the turning point. ETF investors and the broader market seem to be seeing through the noise and concentrating on fundamentals. Tesla might be facing choppy waters today, but it remains an ETF pick and is at the center of the future of mobility and innovation.
As the EV industry continues to grow, ETFs that accept Tesla&#8217;s long-term vision along with the emergence of legitimate challengers such as BYD might be the most balanced way to go.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45570155/new-usng-etf-targets-natural-gas-infrastructure-amid-rising-energy-demand">Amplify, Samsung Launch Natural Gas ETF To Power Up AI-Era Infrastructure Boom</a></li>
</ul>

Sector ETFs

Global

Trading Ideas

ETFs

AAPL

ARKK

BYDDY

DRIV

IDRV

KARS

NVDA

TSLA

BYD Outsells Tesla In Europe, But These ETFs Still Back Elon's EV Empire

Shares of Urban Outfitters Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) rallied after the company Wednesday reported its <a href="https://www.benzinga.com/news/earnings/25/05/45553566/urban-outfitters-shares-rally-on-record-q1-revenues-details">first-quarter results</a>.
The announcement came amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
JPMorgan On Urban Outfitters
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/586bcbd9351b9b0001ab738c/matthew-boss">Analyst Matthew Boss</a> reiterated an Overweight rating while raising the price target from $63 to $78.
Urban Outfitters reported quarterly earnings of $1.16 per share, 38% above Street expectations of 84 cents per share, Boss said in a note. He added that the outperformance was driven by same-store-sales growth of 5%, coming in above expectations of 3.4%, and adjusted gross margin expansion of 240 (basis points) bps year-on-year to 36.8%.
The quarter's same-store-sales growth "included positive comp growth across all three banners," which has happened for the first time in three years, the analyst wrote. For the second quarter, management guided to high-single-digit percentage growth in consolidated sales growth, with mid-single-digit percentage growth in same-store sales, above Street's 3.4% projection, he further stated.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Telsey Advisory Group On Urban Outfitters
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5888c53977f9dd0001877a22/dana-telsey">Analyst Dana Telsey</a> maintained a Market Perform rating, while lifting the price target from $59 to $72.
Telsey said that Urban Outfitters' adjusted earnings grew to $1.16 per share from 69 cents per share in the same quarter last year. Total sales grew 10.7% to $1.330 billion, surpassing consensus of 7.6% to $1.292 billion, she added.  
"After a solid finish to FY24, momentum continued into FY25 with a healthy beat across the board in the first quarter," the analyst wrote. The second-quarter guidance was "encouraging," given the challenging macro environment, as it reflects "continued topline momentum across brands along with margin expansion and earnings growth," she further stated. &nbsp;
URBN Price Action: Shares of Urban Outfitters had risen by 22.01% to $72.72 at the time of publication on Thursday.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45262278/under-armour-faces-tough-road-ahead-says-analyst"> Urban Outfitters Navigates Tariff Headwinds With Diversification Strategies: No Country &#8216;Accounts For More Than 25%&#8217; Of Production</a></li>
</ul>
Photo: Vladislav Gajic/Shutterstock

Analyst Color

Earnings Beats

Reiteration

Movers

URBN

Urban Outfitters Surges After Q1 Beat: Analysts Highlight Margin Strength, Sales Momentum

Newmark Group, Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/NMRK#NASDAQ">NMRK</a>) ("Newmark" or "the Company"), a leading commercial real estate advisor and service provider to large institutional investors, global corporations, and other owners and occupiers, announces the company arranged a $7.1 billion construction loan for Blue Owl Capital, Inc., Crusoe and Primary Digital Infrastructure. The loan, provided by a consortium led by J.P. Morgan, will fund the second phase of a <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4434036-1&amp;h=2693766533&amp;u=https%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2025%2F05%2F21%2F3085765%2F0%2Fen%2FCrusoe-Blue-Owl-Capital-and-Primary-Digital-Infrastructure-Enter-Second-Phase-of-15-Billion-Joint-Venture-to-Fund-AI-Data-Center-in-Abilene-Texas.html&amp;a=%2415+billion+joint+venture">$15 billion joint venture</a> to fund a 1.2-gigawatt AI data center in Abilene, Texas.
Under the terms of the joint venture, Crusoe in combination with funds managed by Blue Owl's Real Assets platform along with Primary Digital Infrastructure will jointly sponsor the construction of six new buildings, which will bring the center to eight buildings upon completion. Construction of the first phase, comprising two buildings and 200+ megawatts, began in June 2024 and is expected to be energized in the first half of 2025. Construction of the second phase, consisting of the six additional buildings and a total of 1.2 gigawatts, began in March 2025 and is expected to be energized in mid-2026, setting a new bar for the speed of delivery for greenfield, hyperscale digital infrastructure projects.

NMRK

Newmark Group Arranges $7.1B Construction Loan For Blue Owl Capital, Crusoe And Primary Digital Infrastructure

<a href="https://cloud.google.com/blog/products/ai-machine-learning/anthropics-claude-opus-4-and-claude-sonnet-4-on-vertex-ai/" title="https://cloud.google.com/blog/products/ai-machine-learning/anthropics-claude-opus-4-and-claude-sonnet-4-on-vertex-ai/">https://cloud.google.com/blog/products/ai-machine-learning/anthropics-claude-opus-4-and-claude-sonnet-4-on-vertex-ai/</a>

AMZN

GOOG

GOOGL

MSFT

Update: 'Announcing Anthropic's Claude Opus 4 and Claude Sonnet 4 on Vertex AI' - Google Cloud

Citigroup analyst Alicia Yap maintains Baidu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) with a Buy and lowers the price target from $139 to $138.

BIDU

Citigroup Maintains Buy on Baidu, Lowers Price Target to $138

WIIM

Utilities ETFs are trading lower. Weakness may be due to recent strength in Treasury yields, which could drive a rotation out of income-paying sectors.

Rumors

TOST

Watching Toast, Inc.; Hearing Investor Business Daily SwingTrader Buys Stock

Alphabet shares are trading higher. The stock may be rising on continued momentum following the company's annual developer conference earlier this week, during which it unveiled the Veo 3 upgrade to its AI video generation tool.

HNGE

Hinge Health IPO Shares Open For Trade At $39.25/Share; IPO Priced At $32/Share On 13.7M Shares

Citigroup analyst Yigal Nochomovitz maintains Apellis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLS#NASDAQ">APLS</a>) with a Buy and lowers the price target from $49 to $41.

APLS

Citigroup Maintains Buy on Apellis Pharmaceuticals, Lowers Price Target to $41

Shares of Snowflake Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) rallied after the company Wednesday reported its <a href="https://www.benzinga.com/news/earnings/25/05/45553121/snowflake-q1-earnings-revenue-eps-beat-estimates-ai-data-cloud-company-sees-25-growth-ahead-shares-climb">first-quarter results</a>.
The announcement came amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
Piper Sandler On Snowflake
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/586e4055351b9b00018beeab/brent-bracelin">Analyst Brent Bracelin</a> reiterated an Overweight rating, while raising the price target from $175 to $215.
Snowflake's total revenue surpassed $1 billion in the first quarter, driven by "another quarter of strong execution and better-than-expected contribution from new products," Bracelin said in a note. Large deal momentum continued, with the company inking two deals worth more than $100 million during the quarter, he added.
These deals contributed to Snowflake's healthy backlog metrics, with cRPO (current remaining performance obligation) accelerating to 31% year-on-year, from the previous quarter's 27%, the analyst stated. "Management has not yet witnessed any negative macro impacts, partially attributable to a more mature customer base, and even cited strong customer net adds (451 vs. 357 one year ago)," he further wrote.
Stifel On Snowflake
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/585beadbb5a482000151d186/brad-reback">Analyst Brad Reback</a> maintained a Buy rating, while lifting the price target from $210 to $220.
Snowflake posted a strong quarter, with growth in product revenue accelerating to 4%, from 3% in the previous quarter, Reback said. This was driven by "outperformance from newer products (Snowpark, Dynamic tables), no tangible impact from the macro, and broad-based consumption strength," he added.
The company's operating margins came in better than expected, with operating expenses growing only 15% year-on-year, a sharp deceleration from 36% in the first quarter of the last fiscal year, the analyst stated. With Snowflake yet to reap "the full benefits from the R&amp;D hiring changes," the current margin gains appear sustainable, he further wrote.
JMP Securities On Snowflake
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5846fffaee7bf6000154d141/patrick-walravens">Analyst Patrick Walravens</a> reaffirmed a Market Outperform rating, while raising the price target from $201 to $245.
Snowflake reported total revenue of $1.04 billion, beating consensus of $1.01 billion, Walravens said. The company's non-GAAP earnings of 24 cents per share surpassed expectations of 21 cents per share, he added.
The company's second-quarter guidance came in better than expected, with product revenue of $1.035-$1.040 billion above consensus $1.021 billion, representing 25% year-on-year growth and non-GAAP operating margin of 8% ahead of consensus of 7%, the analyst stated. "Snowflake addresses a huge opportunity that is expected to double to $342B in 2028 from $152B in 2023," he further wrote.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Truist Securities On Snowflake
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/57fdefd3ac6af40001334e3e/joel-fishbein">Analyst Joel Fishbein</a> reiterated a Buy rating, while lifting the price target from $210 to $235.
Snowflake delivered a strong beat and raise quarter, "driven by both core momentum and the adoption of new workloads," Fishbein said. Management raised their fiscal 2026 product revenue growth guidance to 25%, from their prior projection of 24%, he added.
"We did not hear signs of macro uncertainty impacting consumption on the call and believe that they are establishing the foundation of a strong go to market motion in the emerging AI landscape," the analyst further wrote.
Oppenheimer On Snowflake
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5937f6b185b07a0001ac364f/ittai-kidron">Analyst Ittai Kidron</a> maintained an Outperform rating, while raising the price target from $201 to $225.
Snowflake delivered strong quarterly results, driven by "broad-based demand and steady consumption trends," Kidron said. The company's total customers grew by 18.9% year-on-year to 11,578 in the quarter, he added.
"In addition, better-than-expected Snowpark and Dynamic Tables activity and strong AI adoption (5,200+ accounts) suggest that newer products are resonating with customers," the analyst wrote. He named Snowflake as a top pick.
Rosenblatt Securities On Snowflake
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/60081c88879cba00010420fb/blair-abernethy">Analyst Blair Abernethy</a> reaffirmed a Buy rating, while raising the price target from $205 to $210.
Snowflake reported margins of 9%, versus Rosenblatt's 5% estimate, on the back of its revenue beat and ongoing efficiency improvements, Abernethy said. Snowflake had strong renewals during the quarter, including two deals worth over $100 million each, he added.
The company's trailing NRR (net revenue retention) remained healthy, at 124%, the analyst stated. "We believe Snowflake's much improved product development cadence last year is clearly resonating with existing customers, driving increasing consumption levels," he further wrote.
Needham On Snowflake
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/601a8839a6fe6f00010c6966/mike-cikos">Analyst Mike Cikos</a> reiterated a Buy rating, while lifting the price target from $215 to $230.
Snowflake outperformed its revenue guidance by $36.8 million and raised its full-year outlook by $45 million, Cikos said. For the second quarter, the company's revenue guidance came in $15.1 million above consensus, he added.
"Investors are hunting for high-growth companies, and we believe Snowflake&#8217;s updated FY26 Revenue outlook for 25% yr-yr growth answers the call," the analyst wrote. GenAI is likely to be "a long-term secular tailwind to Snowflake&#8217;s growth," he further stated.
SNOW Price Action: Shares of Snowflake had risen by 10.3% to $197.55 at the time of publication on Thursday.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45262278/under-armour-faces-tough-road-ahead-says-analyst"> Snowflake Jumps 8% Pre-Market After Piper Sander Hikes Price Target To $215, Calls It &#8216;High-Conviction Growth Play&#8217;</a></li>
</ul>
Photo: Shutterstock

SNOW

Snowflake Pops After Solid Quarter: Analysts See Strength In AI, New Workloads

<h3>Gainers</h3>
<ul>
<li>Advance Auto Parts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) stock moved upwards by 52.0% to $47.59 during Thursday's regular session. The company's market cap stands at $2.8 billion. The company's, Q1 earnings came out today. </li>
<li>Raytech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAY#NASDAQ">RAY</a>) shares moved upwards by 28.88% to $2.32. The company's market cap stands at $40.8 million. </li>
<li>YSX Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YSXT#NASDAQ">YSXT</a>) shares moved upwards by 26.2% to $5.49. The company's market cap stands at $128.6 million. </li>
<li>Classover Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KIDZ#NASDAQ">KIDZ</a>) stock increased by 23.66% to $3.61. The market value of their outstanding shares is at $85.8 million. </li>
<li>SharpLink Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) stock moved upwards by 22.22% to $3.41. The market value of their outstanding shares is at $1.9 million. </li>
<li>Urban Outfitters (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) shares rose 21.85% to $72.62. The company's market cap stands at $6.7 billion. The company's, Q1 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Netclass Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTCL#NASDAQ">NTCL</a>) shares fell 31.9% to $6.03 during Thursday's regular session. The company's market cap stands at $107.5 million. </li>
<li>Lottery.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRY#NASDAQ">LTRY</a>) stock fell 18.62% to $1.45. The company's market cap stands at $27.3 million. The company's, Q1 earnings came out yesterday. </li>
<li>Fenbo Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEBO#NASDAQ">FEBO</a>) stock fell 14.84% to $1.08. The market value of their outstanding shares is at $11.9 million. </li>
<li>Greenlane Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) stock fell 14.59% to $0.01. The company's market cap stands at $3.2 million. </li>
<li>MEDIROM Healthcare Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRM#NASDAQ">MRM</a>) stock decreased by 12.36% to $1.56. The market value of their outstanding shares is at $12.3 million. As per the news, the FY earnings report came out 2 days ago. </li>
<li>ZHONGCHAO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCMD#NASDAQ">ZCMD</a>) shares decreased by 9.69% to $1.17. The company's market cap stands at $29.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FEBO

GNLN

KIDZ

LTRY

NTCL

SBET

YSXT

ZCMD

12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Vigil Neuroscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIGL#NASDAQ">VIGL</a>) shares moved upwards by 241.8% to $7.89 during Thursday's regular session. The company's market cap stands at $368.4 million. </li>
<li>Instil Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIL#NASDAQ">TIL</a>) stock increased by 48.15% to $24.03. The market value of their outstanding shares is at $157.6 million. </li>
<li>Eyenovia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) stock rose 32.85% to $1.86. The company's market cap stands at $5.3 million. As per the news, the Q1 earnings report came out 3 days ago. </li>
<li>Longevity Health Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAGE#NASDAQ">XAGE</a>) stock rose 27.77% to $3.91. The market value of their outstanding shares is at $3.9 million. </li>
<li>Prenetics Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRE#NASDAQ">PRE</a>) shares increased by 22.86% to $9.94. The company's market cap stands at $121.4 million. </li>
<li>Ventyx Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTYX#NASDAQ">VTYX</a>) stock rose 21.24% to $1.85. The market value of their outstanding shares is at $132.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>CEL-SCI (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CVM#AMEX">CVM</a>) stock fell 45.5% to $2.46 during Thursday's regular session. The company's market cap stands at $7.4 million. </li>
<li>Basel Medical Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMGL#NASDAQ">BMGL</a>) shares fell 31.29% to $1.28. The market value of their outstanding shares is at $24.1 million. </li>
<li>Catheter Precision (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#AMEX">VTAK</a>) stock fell 30.47% to $0.21. The company's market cap stands at $2.3 million. </li>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) stock declined by 21.32% to $0.0. </li>
<li>Aptevo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) stock fell 21.04% to $0.3. The market value of their outstanding shares is at $2.3 million. </li>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) shares declined by 15.01% to $0.01. As per the press release, Q1 earnings came out 2 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APVO

BMGL

EYEN

HCTI

PLRZ

VIGL

VTAK

VTYX

Longevity Health Holdings, Inc. - Common Stock

XAGE

12 Health Care Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Northann (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NCL#AMEX">NCL</a>) stock rose 26.3% to $0.9 during Thursday's regular session. The market value of their outstanding shares is at $50.0 million. </li>
<li>Safe &amp; Green Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) stock moved upwards by 25.57% to $0.55. The company's market cap stands at $3.8 million. </li>
<li>JVSPAC Acquisition Corp. - Right (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JVSAR#NASDAQ">JVSAR</a>) stock moved upwards by 19.96% to $0.36. </li>
<li>Team (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TISI#NYSE">TISI</a>) stock moved upwards by 16.88% to $21.84. The company's market cap stands at $98.1 million. </li>
<li>Ming Shing Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSW#NASDAQ">MSW</a>) shares moved upwards by 15.29% to $5.05. The company's market cap stands at $65.5 million. </li>
<li>Graphjet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) stock rose 14.49% to $0.18. The market value of their outstanding shares is at $27.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Sunrun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) shares decreased by 39.8% to $6.42 during Thursday's regular session. The company's market cap stands at $1.4 billion. </li>
<li>Complete Solaria (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWR#NASDAQ">SPWR</a>) stock decreased by 19.88% to $1.37. The company's market cap stands at $101.0 million. </li>
<li>Freight Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRGT#NASDAQ">FRGT</a>) stock decreased by 19.18% to $0.8. The market value of their outstanding shares is at $1.8 million. As per the news, the Q1 earnings report came out 4 days ago. </li>
<li>ClearSign Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIR#NASDAQ">CLIR</a>) shares fell 15.5% to $0.6. The market value of their outstanding shares is at $31.4 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>EnerSys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENS#NYSE">ENS</a>) stock declined by 15.18% to $81.01. The market value of their outstanding shares is at $3.1 billion. The company's, Q4 earnings came out yesterday. </li>
<li>Hyperscale Data (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GPUS#AMEX">GPUS</a>) stock declined by 15.14% to $6.0. The market value of their outstanding shares is at $10.2 million. As per the news, the Q1 earnings report came out 2 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLIR

FRGT

GPUS

JVSAR

Nuveen Insured California Premium Fund Ii

SGBX

SPWR

TISI

12 Industrials Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Navitas Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) stock moved upwards by 154.2% to $4.86 during Thursday's regular session. The market value of their outstanding shares is at $931.2 million. </li>
<li>Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) shares moved upwards by 42.81% to $1.83. The market value of their outstanding shares is at $284.4 million. </li>
<li>IonQ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) shares rose 34.56% to $45.13. The company's market cap stands at $11.1 billion. </li>
<li>Domo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOMO#NASDAQ">DOMO</a>) stock rose 30.64% to $11.17. The company's market cap stands at $449.0 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>D-Wave Quantum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) stock moved upwards by 24.31% to $19.09. The market value of their outstanding shares is at $5.5 billion. </li>
<li>Rigetti Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) stock moved upwards by 23.81% to $13.57. The company's market cap stands at $3.9 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>SolarEdge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) shares decreased by 25.6% to $14.77 during Thursday's regular session. The market value of their outstanding shares is at $872.0 million. </li>
<li>Enphase Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) stock decreased by 19.37% to $38.13. The market value of their outstanding shares is at $5.0 billion. </li>
<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) stock declined by 18.07% to $1.86. The company's market cap stands at $48.0 million. </li>
<li>ClearOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRO#NASDAQ">CLRO</a>) stock decreased by 18.03% to $0.39. The company's market cap stands at $10.2 million. As per the news, the Q1 earnings report came out 3 days ago. </li>
<li>Maxeon Solar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAXN#NASDAQ">MAXN</a>) shares fell 11.1% to $2.92. The company's market cap stands at $48.8 million. </li>
<li>Fatpipe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATN#NASDAQ">FATN</a>) stock decreased by 10.28% to $10.39. The market value of their outstanding shares is at $142.5 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLRO

DOMO

ENPH

FATN

IONQ

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

NVTS

QBTS

RGTI

SEDG

WOLF

12 Information Technology Stocks Moving In Thursday's Intraday Session

Wall Street edges higher as GOP tax bill clears the House and bond yields ease, helping investors shake off prior losses while digesting mixed <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45567476/us-business-activity-rebounds-in-may-but-tariff-fueled-inflation-surges-at-fastest-pace-in-3-years">May business activity data.</a>
President Donald Trump's "one big beautiful tax bill" narrowly passed the House in a 215-214 vote and now moves to the Senate. According to the Congressional Budget Office, the proposed legislation is projected to add approximately $3 trillion to the national deficit over the next decade.
U.S. Treasury yields saw a whipsaw session, with the 30-year bond yield initially spiking to 5.15% before retreating by 9 basis points to 5.06% by midday in New York. The reversal in long-term rates signaled renewed investor appetite for long-duration bonds amid attractive yields.
Wednesday's sharp rise in yields had triggered a broad afternoon selloff in equities, but Thursday's pullback eased pressure on risk assets and improved investor sentiment.
The S&amp;P 500 rose 0.3% to 5,860 on Thursday, slightly recouping losses from the previous session. The tech-heavy Nasdaq 100 outperformed with a 0.7% gain.
Technology and consumer discretionary stocks led gains, riding momentum from falling yields. In contrast, defensive sectors like utilities and healthcare lagged. 
The U.S. dollar index (DXY) is on track to snap a three-day losing streak, supported by stronger-than-expected Purchasing Managers' Index (PMI) data for May. While the surveys pointed to solid growth, they also revealed renewed inflationary pressures, which tempered hopes for near-term Federal Reserve rate cuts.
Markets now fully price in a 25-basis-point rate cut only by December 2025, compared to prior expectations of an October move, based on CME Group's FedWatch Tool.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) extended its 2025 rally, jumping 2% above $111,000 to set fresh all-time highs. The world's largest cryptocurrency is now up 20% year-to-date. 
Gold prices, however, fell 0.7% to trade below $3,200 per ounce. Despite Thursday's drop, the precious metal has surged 25% so far in 2025, outperforming other major asset classes, continuing to attract inflows amid sticky inflation and uncertain fiscal policy paths.
<h3 class="wp-block-heading">Thursday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %Chg</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,220.06</td>
<td>0.7%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,861.99</td>
<td>0.3%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>41,976.57</td>
<td>0.3%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,049.02</td>
<td>0.1%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:20 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul class="wp-block-list">
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) inched 0.3% up to $584.61.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) inched 0.2% higher to $419.70.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;rose 0.7% to $516.50.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) inched 0.1% higher to $203.51.</li>
<li>The&nbsp;Consumer Discretionary&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) outperformed, up 0.6%; the&nbsp;Utilities&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>) lagged, down 1.5%.</li>
</ul>
<h3 class="wp-block-heading">Thursday&#8217;s Stock Movers</h3>
Stocks reacting to earnings reports included: 
<ul class="wp-block-list">
<li>Analog Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NASDAQ">ADI</a>) down 3.88%</li>
<li>Ralph Lauren Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RL#NYSE">RL</a>) up 0.51%</li>
<li>BJ&#8217;s Wholesale Club Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>) down 0.92%</li>
<li>e.l.f. Beauty, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) up 3.38%</li>
<li>SM Energy Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SM#NYSE">SM</a>) down 0.35%</li>
</ul>
Solar stocks tumbled after the GOP tax bill cleared the House, with the sector seeing sharp losses amid concerns over reduced clean energy incentives.
<ul class="wp-block-list">
<li>Sunrun Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) down 39%</li>
<li>Invesco Solar ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TAN#NASDAQ">TAN</a>) down 8%</li>
<li>Enphase Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) down 19%</li>
</ul>
As the tax bill suggests increased deficits that could boost spending in sectors like defense and homeland security, tech-focused defense stocks moved higher.
<ul class="wp-block-list">
<li>Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) up 4.5%</li>
<li>CrowdStrike Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) up 2.6%</li>
</ul>
Stocks slated to report earnings after the close include Ross Stores Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>), CryoPort Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYRX#NASDAQ">CYRX</a>), Workday Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>), Intuit Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>), Autodesk Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) and Deckers Outdoor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>).
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/government/regulations/25/05/45569891/big-tax-cuts-big-deficits-wall-street-winners-and-losers-emerge">Big Tax Cuts, Big Deficits: Wall Street Winners And Losers Emerge </a></li>
</ul>
Photo: Shutterstock

$BTC

ADSK

CRWD

CYRX

DECK

SPDR Dow Jones Industrial Average ETF Trust

INTU

PLTR

ROST

WDAY

Select Sector SPDR-Consumer Discretionary

Stocks Rebound As Treasury Yields Fall, Bitcoin Tops $111,000: What's Driving Markets Thursday?

Citigroup analyst Paul Lejuez maintains Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) with a Neutral and lowers the price target from $97 to $94.

Citigroup Maintains Neutral on Target, Lowers Price Target to $94

iShares Dow Jones US Energy Sector Index Fund

MELI

CNBC Halftime Report Final Trades: MercadoLibre, Delta Air Lines, Toast, iShares U.S. Energy ETF

Investors with a lot of money to spend have taken a bullish stance on NextEra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NEE, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 24 uncommon options trades for NextEra Energy.
This isn't normal.
The overall sentiment of these big-money traders is split between 54% bullish and 33%, bearish.
Out of all of the special options we uncovered, 13 are puts, for a total amount of $2,183,522, and 11 are calls, for a total amount of $1,063,444.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $40.0 and $75.0 for NextEra Energy, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for NextEra Energy options trades today is 4187.53 with a total volume of 23,694.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for NextEra Energy's big money trades within a strike price range of $40.0 to $75.0 over the last 30 days.
<h3>NextEra Energy Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747933290_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NEE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$3.2</td>
<td>$2.89</td>
<td>$2.9</td>
<td>$57.50</td>
<td>$870.0K</td>
<td>78</td>
<td>3.0K</td>
</tr>
<tr>
<td>NEE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$26.65</td>
<td>$26.35</td>
<td>$26.35</td>
<td>$40.00</td>
<td>$313.5K</td>
<td>23.1K</td>
<td>2.2K</td>
</tr>
<tr>
<td>NEE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$2.96</td>
<td>$2.25</td>
<td>$2.7</td>
<td>$65.00</td>
<td>$270.0K</td>
<td>4.1K</td>
<td>4.6K</td>
</tr>
<tr>
<td>NEE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/30/25</td>
<td>$5.45</td>
<td>$5.3</td>
<td>$5.33</td>
<td>$71.00</td>
<td>$216.9K</td>
<td>2.4K</td>
<td>1.0K</td>
</tr>
<tr>
<td>NEE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$1.2</td>
<td>$0.68</td>
<td>$1.09</td>
<td>$62.50</td>
<td>$163.6K</td>
<td>3.7K</td>
<td>1.5K</td>
</tr>
</tbody>
</table>

<h3>About NextEra Energy</h3>
NextEra Energy's regulated utility, Florida Power &amp; Light, is the largest rate-regulated utility in Florida. The utility distributes power to over 6 million customer accounts in Florida and owns 36 gigawatts of generation. FP&amp;L contributes roughly 70% of NextEra's consolidated operating earnings. NextEra Energy Resources, the renewable energy segment, generates and sells power throughout the United States and Canada with more than 37 GW of generation capacity, including natural gas, nuclear, wind, and solar.
In light of the recent options history for NextEra Energy, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is NextEra Energy Standing Right Now?</h3>
<ul>
<li>With a trading volume of 21,263,907, the price of NEE is down by -8.86%, reaching $65.2.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 62 days from now.</li>
</ul>
<h3>What Analysts Are Saying About NextEra Energy</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $81.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on NextEra Energy, which currently sits at a price target of $97. 
&#x2A; An analyst from Barclays has decided to maintain their Equal-Weight rating on NextEra Energy, which currently sits at a price target of $65. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest NextEra Energy options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

Markets

What the Options Market Tells Us About NextEra Energy

Press Releases

Collegium to Participate in Upcoming Investor Conferences

Health Care

General

Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

Management

Collegium Announces Updates to its Board of Directors and Executive Leadership Team

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine's Annual Meeting

Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

Collegium to Report First Quarter 2025 Financial Results on May 8, 2025

Earnings

Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

Collegium Announces $25 Million Accelerated Share Repurchase Program

AVTX

BHVN

COLL

TRVI

Amylyx Pharmaceuticals, Inc. - Common Stock

Amylyx Pharmaceuticals

Amphastar Pharmaceuticals, Inc. - Common Stock

Amphastar Pharma

ANI Pharmaceuticals

Cormedix

Enliven Therapeutics, Inc. - Common Stock

Enliven Therapeutics

Evolus

Eton Pharmaceuticals, Inc. - Common Stock

Eton Pharmaceuticals

Edgewise Therapeutics, Inc. - Common Stock

Edgewise Therapeutics

GH Research

Structure Therapeutics Inc. - American Depositary Shares

Structure Therapeutics

Harrow

Indivior

Innoviva

LENZ Therapeutics

Liquidia

Nuvation Bio

Ocular Therapeutix

Phibro Animal Health Corporation - Class A Common Stock

Phibro Animal Health

Pacira BioSciences

Supernus Pharmaceuticals, Inc. - Common Stock

Supernus Pharmaceuticals

Tarsus Pharmaceuticals, Inc. - Common Stock

Comments

Collegium Pharmaceutical

空売り

Collegium Pharmaceutical (NASDAQ:COLL) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル